Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.

Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC.

N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. No abstract available.

2.

An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001-2002.

Guerrin-Tran E, Thiolet JM, Rousseau C, Henry S, Poirier C, Che D, Vinas JM, Jarlier V, Robert J.

Eur J Epidemiol. 2006;21(10):783-5. Epub 2006 Nov 15.

PMID:
17106759
3.

Drug-resistant tuberculosis: what is to be done?

Schluger NW.

Chest. 2009 Aug;136(2):333-335. doi: 10.1378/chest.09-0785. No abstract available.

PMID:
19666753
4.

Tuberculosis, drug resistance, and the history of modern medicine.

Keshavjee S, Farmer PE.

N Engl J Med. 2012 Sep 6;367(10):931-6. doi: 10.1056/NEJMra1205429. No abstract available.

5.

[Multiresistant tuberculosis in Brazil: history and control].

Dalcolmo MP, Andrade MK, Picon PD.

Rev Saude Publica. 2007 Sep;41 Suppl 1:34-42. Portuguese.

6.

Multidrug resistant tuberculosis: a continuing crisis.

Burki T.

Lancet Infect Dis. 2016 Dec;16(12):1337-1338. doi: 10.1016/S1473-3099(16)30479-0. Epub 2016 Nov 15. No abstract available.

PMID:
27998601
7.

Drug-resistant Mycobacterium tuberculosis, Taiwan.

Jou R, Chuang PC, Wu YS, Yan JJ, Luh KT.

Emerg Infect Dis. 2006 May;12(5):871-2. No abstract available.

8.

Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.

Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, Raviglione M; WHO/International Union Against Tuberculosis And Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance.

Lancet. 2006 Dec 16;368(9553):2142-54.

PMID:
17174706
9.

Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014.

Lemus D, Echemendía M, Díaz R, Llanes MJ, Suárez L, Marrero A.

MEDICC Rev. 2017 Jan;19(1):10-15.

10.

Dynamics of multidrug resistant tuberculosis in Veracruz, México between 2002 and 2008.

Zenteno-Cuevas R, Rubi A, Fuentes-Dominguez J, Lara-Gonzalez JL, Escobar-Mesa A.

J Infect Dev Ctries. 2010 Nov 24;4(11):776-8. No abstract available.

11.

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil.

Micheletti VC, Moreira Jda S, Ribeiro MO, Kritski AL, Braga JU.

J Bras Pneumol. 2014 Mar-Apr;40(2):155-63. English, Portuguese.

12.
13.

Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.

Loutet MG, Davidson JA, Brown T, Dedicoat M, Thomas HL, Lalor MK.

Emerg Infect Dis. 2018 Mar;24(3):524-533. doi: 10.3201/eid2403.171362.

14.

Multidrug-resistant tuberculosis--can the tide be turned?

Zumla A, Grange JM.

Lancet Infect Dis. 2001 Oct;1(3):199-202. Review.

PMID:
11871496
15.

Treatment duration for patients with drug-resistant tuberculosis, United States.

Winston CA, Mitruka K.

Emerg Infect Dis. 2012 Jul;18(7):1201-2. doi: 10.3201/eid1807.120261. No abstract available.

16.

[Multidrug-resistant tuberculosis: current epidemiology, therapeutic regimens, new drugs].

Gómez-Ayerbe C, Vivancos MJ, Moreno S.

Rev Esp Quimioter. 2016 Sep;29 Suppl 1:35-8. Review. Spanish.

17.

[Surveillance of resistance to antitubercular drugs in Cuba, 2000-2009].

Montoro E, Lemus D, Echemendia M, Diaz R, Mederos L, Martinez MR, Llop A, Llanes MJ.

Rev Panam Salud Publica. 2011 Dec;30(6):615-8. Spanish.

18.

[Occurence of primary resistance in hospital patients with respiratory tuberculosis].

Serdarević H, Bogdanović M, Travnik H, Simeonov L.

Tuberkuloza. 1966 Jan-Jun;18(1-3):220-7. Bosnian. No abstract available.

PMID:
16296090
19.

Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?

Velayati AA, Farnia P, Masjedi MR, Hoffner S.

Int J Tuberc Lung Dis. 2013 Jun;17(6):849-50. doi: 10.5588/ijtld.13.0066. No abstract available.

PMID:
23676176
20.

Beijing lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007-2011.

Panaiotov S, Bachiyska E, Yordanova S, Atanasova Y, Brankova N, Levterova V, Sengstake S, Anthony R, Bergval I, Sola C, Kantardjiev T.

Emerg Infect Dis. 2014 Nov;20(11):1899-901. doi: 10.3201/eid2011.140468.

Supplemental Content

Support Center